Biostack: Nontoxic Metabolite Detection from Live Tissue by Strakosas, Xenofon et al.
RESEARCH ARTICLE
www.advancedscience.com
Biostack: Nontoxic Metabolite Detection from Live Tissue
Xenofon Strakosas,* Mary J. Donahue, Adel Hama, Marcel Braendlein, Miriam Huerta,
Daniel T. Simon, Magnus Berggren, George G. Malliaras, and Roisin M. Owens*
There is increasing demand for direct in situ metabolite monitoring from cell
cultures and in vivo using implantable devices. Electrochemical biosensors
are commonly preferred due to their low-cost, high sensitivity, and low
complexity. Metabolite detection, however, in cultured cells or sensitive tissue
is rarely shown. Commonly, glucose sensing occurs indirectly by measuring
the concentration of hydrogen peroxide, which is a by-product of the
conversion of glucose by glucose oxidase. However, continuous production of
hydrogen peroxide in cell media with high glucose is toxic to adjacent cells or
tissue. This challenge is overcome through a novel, stacked enzyme
configuration. A primary enzyme is used to provide analyte sensitivity, along
with a secondary enzyme which converts H2O2 back to O2. The secondary
enzyme is functionalized as the outermost layer of the device. Thus,
production of H2O2 remains local to the sensor and its concentration in the
extracellular environment does not increase. This “biostack” is integrated
with organic electrochemical transistors to demonstrate sensors that monitor
glucose concentration in cell cultures in situ. The “biostack” renders the
sensors nontoxic for cells and provides highly sensitive and stable detection
of metabolites.
1. Introduction
Although secreted metabolites may be monitored using offline
biosensors, there is increasing demand for direct in situ metabo-
lite monitoring from live cell cultures as well as in vivo with
implanted devices. Applications include monitoring of metabo-
lites such as glucose and lactate, key components for assessing
metabolism in cells and tissues, and important indicators for
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diseases such as epilepsy, diabetes, and
cancer.[1,2] For example, glucose is a well-
known biomarker in the study and diagno-
sis of diabetes. During an epileptic crisis
there is an increased consumption of glu-
cose and increased secretion of lactate. [3,4]
Additionally, drugs or a pathogen may alter
the metabolism of a cell, and in vitro drug
testing platforms integrated with live cells
have been developed for toxicology tests.[5]
Biosensors represent a useful technology
to understand and diagnose diseases. An
effective biosensor must have high sensi-
tivity and high specificity. A host of novel
technologies have emerged with sensitivi-
ties into the attomolar range,[6,7] however,
achieving specificity relies on having a good
biorecognition element (BRE). Nature’s so-
lution is to use proteins to achieve speci-
ficity, easily distinguishing between pairs of
enantiomers. Incorporation of proteins into
biosensors as BREs can be very effective,
however, if the sensor must operate in vivo,
or even in vitro (with live cells), a variety of
problems may arise. Many metabolite sen-
sors use redox enzymes as the BRE with
an operating principle based on the Clark electrode.[8] An elec-
trode, usually platinum, measures the faradaic current from the
decomposition of hydrogen peroxide (H2O2), which is produced
as a by-product when the relevant metabolites are converted
by their oxidase enzymes. The most advanced electrochemical
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sensors, called second and third generation sensors, employ elec-
trochemically active species bound to polymers for the transfer
of electrons to the transducer. However, the mediators utilized
for these sensors are often cytotoxic.[9] Commercial blood glucose
and lactate sensors are available, but typically necessitate the ex-
traction of a sample (blood, serum, saliva), prior to measurement.
Although there has been a push toward continuous monitoring
of metabolites,[10] challenges have prohibited their widespread
success. These challenges include dual hurdles of low stability
and poor biocompatibility, not only of the transducer but also of
the BRE or its byproducts, and background noise from electroac-
tive species.
An effective strategy for in vivo/in vitro detection of metabo-
lites should thus be specific, sensitive, and capable of operating
in complex matrices such as biological fluids and tissues. For im-
plantable use, mechanical compliance is also required to avoid
extensive immune reaction.[11] Finally, it is exceedingly impor-
tant that the device is stable and biocompatible and that there is
no toxicity either from either the transducer or the BRE and its
byproducts. Organic electronics have emerged as alternatives to
silicon-based electronics used to integrate with live cells and tis-
sues, primarily due to their tissue-like mechanical properties and
their mixed ionic/electronic conduction.[12,13] Among emerging
organic electronic devices, the organic electrochemical transistor
(OECT) has been used extensively for interfacing with biological
systems,[14] and has shown excellent biocompatibility with live
tissues both in vitro[15,16] and in vivo.[17] The OECT displays en-
hanced signal transduction of biological signals[17] and metabo-
lite sensing using the OECT has been demonstrated repeatedly
through coupling of enzymes with and without mediators.[18–21]
In some cases incorporation of materials such as platinum
nanoparticles (Pt-NPs) were used to enhance catalytic activity
have reached sensitivities at the nanomolar range for the detec-
tion of glucose and dopamine.[22,23] A significant advantage of
organic electronic devices such as the OECT is their amenabil-
ity to chemical modification or functionalization.[24] Stability of
metabolite sensing with OECTs has been improved by the co-
valent immobilization of enzymes in close proximity to the ac-
tive electrode.[20,25,26] Owing to their operating principle, however,
such redox enzyme sensors are incompatible with operation in
direct contact with cells and tissue, both due to toxicity of elec-
trochemically active mediators that can leach out of the device
or via the production of H2O2, which is highly toxic to the cells.
When H2O2 is produced as the byproduct of a redox reaction in
the presence of oxygen, a certain proportion will directly transfer
electrons to the transducer; however, a significant amount may
also diffuse into the biological milieu and thus affect the integrity
of the tissue. This results in a limited utilization of current enzy-
matic sensors with live cells.
Here, we report an OECT-based metabolite sensor that is ca-
pable of continuously monitoring relevant metabolites in close
proximity to cells and tissue, without disrupting their normal
function. This is possible through an approach termed here the
“biostack,” in which a layered functionalization approach is used
to place the redox enzyme corresponding to the metabolite of in-
terest as close as possible to the electrode, while the upper layer
consists of horseradish peroxidase (HRP) or catalase (Cat) that
neutralizes the diffusing H2O2. The active enzymes are sepa-
rated by polypeptide spacers that enhance and stabilize the in-
teractions. The inclusion of Pt-NPs improves catalytic efficiency,
and additionally provides a high surface area for charge transfer
reactions to take place as a result of the 3D structure at the gate
electrode (Figure S1, Supporting Information). This simple but
effective stacking approach not only demonstrates sensitivities
tuned to the application at hand, but it also maintains high sta-
bilities in complex in vitro situations, inhibiting toxicity to cells
cultivated adjacent to the electrodes.
2. Results
The metabolite sensors developed here are based on OECT
devices created using previously reported fabrication techniques
on fused silica glass slides.[27] The design allows for the integra-
tion of four glass wells on each glass substrate, used to confine
the electrolyte. In each well there are two planar electrodes used
as gates for the transistors as well as six channels for testing
and measurement as depicted in Figure 1A. Our goal was to
integrate the OECT-based sensors with cells to monitor their
metabolic activities in vitro and in real time (Figure 1B). The
cultured cells create a confluent layer on top of planar OECT
sensors, apart from the gate on which a polyethylene glycol
diacrylate (PEG-DA) gel was drop-cast and crosslinked by UV
radiation, to allow diffusion of metabolites to the gate. In order
to monitor metabolites in vitro, it is necessary to reduce the in-
herent toxicity of first-generation enzymatic metabolite sensors,
which results from the production and out-diffusion of H2O2.
[16]
In the devices developed here, the functionalization and sensing
occurs at the gate electrode, whereas the channel transduces the
signal to an electronic current that can be monitored without
the need of external amplification.[28] A blend of PEDOT:PSS
(poly(3,4-ethylenedioxythiophene) polystyrene sulfonate) with
polyvinyl alcohol (PVA) was used[25] to enable the further
chemical functionalization of the gate electrode according to
the scheme in Figure 1C. The functionalization consists of the
“biostack” approach utilizing sequential deposition of Pt-NPs,
an epoxy silane (GOPs), poly-l-lysine (PLL), glucose oxidase
(GOx) or lactate oxidase (LOx), PLL, and lastly HRP or Cat. Post
device fabrication and prior to “biostack” functionalization, the
Pt-NPs were introduced into the conducting polymer film at the
gate by electrodeposition.[26,29,30] As the reduction potential is
only applied at the gate and not the OECT channels, the Pt-NPs
were deposited only at the gate electrode. Pt was used because
of its excellent catalytic activity in the decomposition of H2O2,
with an additional advantage coming from the high surface
area generated,[31] facilitating an increased and more rapid
breakdown of H2O2 (Figure S1, Supporting Information). After
Pt-NP deposition, a monolayer of a heterobifunctional silane
(3-glycidoxy-propyltrimethoxysilane (GOPS)) was deposited via
chemical vapor deposition (CVD), relying on the binding of
silanol groups to the alcohol group of PVA. This monolayer
binding leaves epoxy groups available for subsequent coupling
to the amine groups in PLL. PLL was drop cast on top of the gate,
left for 2 h, and then washed thoroughly with phosphate buffer
saline (PBS) and deionized (DI) water (Figure 1C i ). The addition
of PLL serves two purposes: It provides a more attractive surface
for subsequent adsorption of enzymes GOx or LOx (with isoelec-
tric points of 4.2 and 4.6 respectively, thus negatively charged at
physiological pH) than bare PEDOT:PSS, which is assumed to
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Figure 1. Design and fabrication of the OECT within the biostack platform. A) Photograph of the device showing the glass wells, gate electrodes, and
channels. Well diameter is 8 mm. B) Schematic showing a cross-section of a portion of the device contained within a glass well, one gate, and one
OECT, integrated with cells. The gates (functionalized and control) of the OECTs are covered with a PEG-DA gel in order to prevent cells from adhering
to the gates. C) Functionalization scheme for the biostack on top of the gate electrodes. An epoxy silane (GOPS) covalently binds to PEDOT:PSS:PVA
and poly-l-lysine (PLL) binds to the epoxy group of the GOPS. Modified glucose oxidase (GOx) with EDC/s-NHS binds to the amine groups of PLL. The
PLL deposition and enzyme activation processes are repeated to immobilize a peroxidase enzyme such as HRP or Cat in a stack configuration on top of
GOx or LOx.
have a significant negative charge near the surface due to excess
PSS. The positively charged PLL thus neutralizes the repulsive
effects between the negatively charged PSS and subsequently
attracts the negatively charged GOx/LOx, resulting in a high
loading of enzyme on the surface (Figure S3A–C, Supporting
Information). Owing to the high molecular weight and linear
structure (and therefore length) of PLL, it can act as an effective
spacer between the enzymatic layers. Prior to deposition, either
GOx or LOx (as indicated) were activated by EDC/s-NHS (1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide/N-hydroxysulfo-
succinimide) chemistry, in order to assist in formation of
covalent bonds with the underlying PLL (Figure 1C ii). [32,33]
Our strategy was designed to covalently immobilize the
GOx/LOx as close as possible to the gate electrode, ensuring that
when glucose is converted to H2O2 it can diffuse rapidly to the Pt-
NP decorated gate electrode, resulting in an increased sensing re-
sponse (Figure 2A) as well as long-term high stability. In the pres-
ence of O2, glucose is converted to gluconolactone by the enzyme
glucose oxidase and lactate is converted to pyruvate by lactate ox-
idase, with H2O2 as a byproduct of the coupled reaction. H2O2 in
turn is catalyzed by the Pt-NPs, giving two electrons to the gate
when a constant positive Vg is applied.
[34] This electron trans-
fer process results in dedoping of the PEDOT channel and thus
modulation of the source–drain current (Id). The modulation is
proportional to the concentration of produced H2O2 and thus of
the analyte (glucose, lactate).[34] Figure 2B shows a representa-
tive curve of the measured current response, when glucose was
added to the system in a range of concentrations from 1 × 10−6
to 5 × 10−3 m. The current modulation was reproducible and de-
pended on the concentration of the analyte for a range of concen-
trations when initial high concentration of glucose was depleted
or when glucose was added with washing steps in between, in
which the electrolyte was replaced with a nonglucose buffer (Fig-
ure S2A–C, Supporting Information). We believe the observed
stability of the sensors over time is a result of covalent binding of
GOx to the substrate. Figure 2C shows the normalized response
calibration curves and control gates, extracted from a glucose sen-
sor prior to (red) and after (black) storage in PBS at 4 °C for
100 d. The sensor is functional in the same glucose concentra-
tion range. This functionality after storage in PBS in Figure 2C,
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Figure 2. Functionalization of OECTs with redox enzymes results in a device with high sensitivity but significant cytotoxicity due to production of hydrogen
peroxide (H2O2). A) Schematic of a device functionalized with GOx, on top of PLL and in close proximity to Pt-NPs. B) Typical current response of a
GOx functionalized device with a constant Vg = 0.4 V upon increasing concentrations of glucose in the electrolyte (the red points indicate addition steps
from 1 × 10−6 to 5 × 10−3 m with the concentration doubling at each step). C) Normalized current response between a freshly functionalized and an
OECT stored in PBS at 4 °C for 100 d. D) Toxicity of the OECT glucose sensor, integrated with an MDCK II epithelial cell line. The cells grow to form a
confluent layer on nonfunctionalized OECTs after 36 h, left panel (top 16 h after seeding the cell, bottom 36 h after seeding the cells). Cells do not grow
on GOx functionalized OECT middle panel. Slower cell growth is observed on an LOx functionalized OECT right panel. The toxicity is attributed to the
production of H2O2 in cell media containing 5 × 10−3 m of glucose. Scale bars: 200 μm.
as well as the measurements in Figure S2A,B in the Support-
ing Information, indicate a covalent arrangement, and likely co-
valent bonding between the GOx/PLL/GOPS/PEDOT:PSS:PVA
layers. Evidence for an increased loading of the GOx enzyme
through the addition of PLL is given by quartz crystal microbal-
ance (QCM) data (Figure S3A,B, Supporting Information). QCM
frequency changes are proportional to the amount of adsorbed
mass on a surface. In the presence of immobilized PLL, the QCM
frequency change during introduction of GOx is larger, and it
remains larger after a washing step, compared to when PLL is
not pre-immobilized on PEDOT:PSS:PVA (Figure S3C, Support-
ing Information). The higher amount of immobilized enzyme
resulted in an enhanced sensitivity and stability of operation of
the device (Figure S3D, Supporting Information).
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Since H2O2 is neutral, only a portion of it is converted at the
Pt-NPs gate electrode and the remainder diffuses out from the
surface to the biological media. If such sensors are to be used in
proximity to live cells or tissue, the H2O2 must be removed. In-
deed, experiments carried out cultivating live cells on the OECT
glucose sensors clearly show that the cells experience significant
toxicity on substrates with GOx functionalized electrodes (Fig-
ure 2D) compared to nonfunctionalized devices or LOx function-
alized electrodes. Madin Darby canine kidney (MDCK II) epithe-
lial cells (canine kidney epithelial cells) cultivated using media
containing galactose as an alternative carbon source, on devices
with GOx functionalized electrodes, showed no evident toxicity,
confirming the role of the glucose enzyme in the toxicity effects
(Figure S4A, Supporting Information). In addition, there is the
appearance of slower growth of cells on LOx functionalized de-
vices at 16 h, but they are fully recovered at 36 h. This indicates
some production of lactate from the cells (there is no lactate in the
media), which is converted to H2O2 at the gate electrode, which
is toxic to the cells. Further experiments cultivating cells in the
presence of media collected from the GOx functionalized devices,
but on tissue culture dishes, also showed cells with rounded mor-
phology and some areas where no cells were grown (Figure S4B,
Supporting Information, black arrows). The changes in the mor-
phology of MDCK cells are a known sign of cell damage.[35,36]
This implies the presence of a soluble toxic compound in the me-
dia (presumably H2O2).
To counter this toxicity, we devised an effective means of scav-
enging H2O2 by the addition of a peroxidase enzyme, in this case
HRP or Cat, which converts the unreacted H2O2 into O2. By re-
peating the same functionalization steps as before, a second layer
of PLL was added (Figure 1A iii), followed by the immobilization
of HRP/Cat, again using EDC/s-NHS activation chemistry (Fig-
ure 1A iv and Figure 3A). QCM measurements showed, as previ-
ously with GOx, that when PLL was added as a spacer between the
first enzyme (GOx/LOx) and the second enzyme (HRP) the fre-
quency shift was higher, indicating that more enzyme remained
on the surface (Figure S3E, Supporting Information). This high-
lights the fact that the second PLL layer helps to bind the sec-
ondary enzyme in the stack configuration. In order to investi-
gate the H2O2 “blocking” ability of the HRP/Cat enzyme, a test
was carried out, by introducing different concentrations of H2O2
into the electrolyte. The normalized current response (NR) was
calculated for both control (only PEDOT:PSS:PVA and Pt-NPs)
and functionalized gates (with biostack layers). The same devices
were measured before and after the functionalization with en-
zymes (Figure S5A, Supporting Information). The NR to H2O2
for a functionalized gate drops significantly compared to the con-
trol gate. This means that H2O2 introduced into the electrolyte,
and diffusing toward the functionalized gate, is neutralized by the
second enzyme, and does not reach the Pt catalytic surface (Fig-
ure S5B, Supporting Information). On the contrary, when differ-
ent glucose concentrations were introduced into the electrolyte,
the signal from the functionalized gate showed a typical sensing
behavior, whereas signal modulation from the control gate was
insignificant (Figure S5C,D, Supporting Information).
The role of HRP or Cat is to render the device nontoxic since
production and consumption of H2O2 will remain local, at the
gate electrode. This will allow integration of cells with the sen-
sors and will additionally reduce interference when multiple sen-
sors are desired within the same electrolyte. To test the ability
of HRP to efficiently neutralize H2O2 while maintaining sen-
sor performance however, a balance must be struck between the
concentration ratio of the primary oxidase enzymes (GOx, LOx)
and the second outer peroxidase enzymes (HRP, Cat), in order
to maintain high sensitivity toward metabolite sensing while de-
creasing the toxicity of the out-diffused H2O2 into the media. By
tuning the concentration of the second enzyme with respect to
the first enzyme, we effectively change the sensitivity of detection
(Figure 3B,C). The NR for glucose detection is slightly shifted to
higher concentrations upon utilization of larger concentration ra-
tios of HRP, as expected. The initial GOx concentration added for
immobilization was 1 mg mL–1, which gave a linear response at
a concentration range between 50 × 10−6 and 1 × 10−3 m. Using
a concentration ratio of HRP/GOx = 1/10 and HRP/GOx = 1/4
the NR shifts slightly. In the case of LOx, an initial concentra-
tion of 5 mg mL–1 was used, which gave a linear response in the
concentration range of 3 × 10−6–200 × 10−6 m. This higher con-
centration of LOx and the resulting sensitivity are desired in or-
der to sense low concentrations of lactate produced by the cells.
The addition of HRP affected more the changes in sensitivity
for LOx functionalization more drastically than that of GOx (Fig-
ure 3B,C). A ratio that allowed good sensitivities as well as high
biocompatibility was HRP /LOx = 1/50. This calibration must be
performed empirically with respect to different activities of dif-
ferent enzymes; however, this is a useful optimization tool and
shows the tunability of the system depending on the application
and concentration range of interest. It should be noted that al-
though HRP usually favors the oxidation of other substrates, pre-
vious work suggests that HRP can scavenge H2O2 and produce
O2 in the absence of other reactants, mimicking the function
of Cat.[37]
To further test both the diffusion of peroxide as well as the sen-
sitivity of the device, an OECT was operated sequentially with one
of two gates, either functionalized only with the primary redox en-
zyme (GOx or LOx; Figure 3D), or functionalized both with the
primary redox enzyme as well as HRP (Figure 3G). In both cases,
control gate electrodes with only Pt-NPs were maintained in the
same electrolyte in order to sense the H2O2 diffusing out from
the functionalized gate. To monitor this out-diffusion of H2O2,
a constant gate voltage Vg = 0.4 V was applied to the function-
alized gate, and the drain current (Id) was recorded (Figure 3E
—GOx; Figure 3F —LOx). After a steady state Id current baseline
was observed, different concentrations of glucose (from 1× 10−6–
2.5 × 10−3 m) or lactate (from 1 × 10−6–250 × 10−6 m) were added,
and between each addition step a waiting time was kept until the
drain Id reached a stable baseline. When switching to the non-
functionalized control gate, the reaction of the decomposition of
the diffused H2O2 in the electrolyte results in a new baseline; a
difference, ΔΙ, of around 400 μA was observed for glucose and
200 μA for lactate. The difference is caused by H2O2 diffusing
into the electrolyte that was produced by the functionalized gate
as GOx or LOx turns over glucose or lactate, respectively. By per-
forming the same measurements after the addition of HRP to the
functionalization ([HRP]/[GOx] = 1/2) and ([HRP]/[LOx] = 1/10),
we observe that when we switch to a control gate the Id baseline
reverts to initial levels (prior to addition of analytes), and no ΔΙ
was observed, indicating that H2O2 has been effectively neutral-
ized (Figure 3H —GOx; Figure 3I —LOx).
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Figure 3. Biostack device functionalized with both redox and peroxidase enzymes. A. Schematic of a device with the addition of second PLL layer and
HRP. B. Binding of HRP on a GOx functionalized gate shifts the glucose detection range to higher concentrations (n = 3 gates for each condition and
two time series measurements for each gate). C) Binding of HRP to an LOx functionalized gate shifts and reduces the sensitivity (n = 3 gates for each
condition and two time series measurements for each gate). D) Illustration of a device operated using two gates: first the OECT is modulated using the
gate functionalized with GOx or LOx (ROx) and secondly using a control gate with only PtNPs. Both gates are located in the same electrolyte. E) Typical
current response of GOx functionalized device without the secondary HRP enzyme layer upon increasing concentrations of glucose in the electrolyte
(a = 0 × 10−6 m, b = 5 × 10−6 m, c = 10 × 10−6 m, d = 20 × 10−6 m, e = 50 × 10−6 m, f = 100 × 10−6 m, g = 250 × 10−6 m, h = 500 × 10−3 m,
i = 1 × 10−3 m, j = 2.5 × 10−3 m, k = 5 × 10−3 m). When the gate is switched to the control gate, a shift in the baseline between functionalized and
control gate is observed. This shift is attributed to diffused H2O2, produced by the catalysis of glucose at the functionalized gate. F) Analogous to (E),
the current response of an LOx functionalized device without the secondary HRP enzyme layer upon increasing concentrations of lactate in the electrolyte
(a = 0 × 10−6 m, b = 1 × 10−6 m, c = 5 × 10−6 m, d = 10 × 10−6 m, e = 20 × 10−6 m, f = 50 × 10−6 m, g = 100 × 10−6 m, h = 250 × 10−6 m, i = 500 × 10−6
m). A similar shift is observed in the baseline, but smaller due to the smaller lactate concentration. G) Illustration of device using one gate functionalized
with GOx/LOx and HRP and one control device with Pt-NPs. H) Similar to (E), addition of the same glucose concentrations shows sensitivity using the
functionalized gate. When changing the OECT gate to the control gate, no shift in the baseline is observed between control and functionalized gate. HRP
is functionalized in the stack configuration therefore prevents or significantly reduces H2O2 diffusion into the electrolyte. I) Similar to (F), the addition
of lactate in solution shows good sensitivity using the LOx/HRP functionalized gate. No shift in the baseline is observed when the gate is switched to
the control.
To validate the nontoxicity of the biostack metabolite detec-
tion, the developed sensors were tested with live cells grown di-
rectly in the wells on the device. For these experiments with live
cells, the gates were functionalized analogous to the protocol for
characterization of the devices, using the biostack approach for
glucose and lactate sensing. Furthermore, 2–5 wt% PEG-DA in
DI water, was drop-cast on top of the gates and polymerized for
3 min under UV light. Owing to its bioinert properties, PEG
prohibits cells from growing on top of the gate (masking the
enzymes) and allows cellular metabolites to diffuse to the gate
electrodes (Figure 4A,B). MDCK II cells were seeded on the de-
vices, forming a confluent layer in 4 d. OECT platforms have
been shown to successfully measure the barrier properties of in-
tegrated epithelial cells.[38] In our sensors, frequency dependent
transconductance values verify the confluency of the cells and
their barrier properties (Figure S6, Supporting Information). The
cutoff frequency of the OECTs prior to seeding the cells is over
1000 Hz, whereas after cell confluency the cutoff frequency is be-
low 100 Hz. These results are in agreement with previous work
on OECT based impedance sensing and show that the cells ex-
hibit barrier properties.[39] After cell confluency, new media was
added to the wells and glucose / lactate sensor measurements
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Figure 4. Detection of metabolites from live tissue cultured on biostack devices. A) Image of GOx/HRP device with PEG-DA gel on gate and MDCK
II cells grown around it. The toxicity of the sensor has been reduced as shown from the cells that are growing and proliferating around the gate. PEG-
DA gel on the gate prevents cells from growing directly on the electrode. Scale bar 200 μm B) Similar to (a), an image of an LOx/HRP device with gel
on the gate and MDCK II cells grown on the neighboring substrate. Scale bar 200 μm. C) Normalized current response of GOx/HRP devices recorded
from fully grown cells after fresh media is introduced. The blue highlighted region shows the time window for the response of a control gate, while the
red area shows the time window for response of a functionalized gate. D) Normalized current response of continuous measurements of the glucose
concentration in MDCK II cells.
were carried out. In more detail, the applied Vg = 0.4 V was
switched between the control gate (only Pt-NPs) and the function-
alized gate. The gate bias was applied to each gate until a steady
state Id baseline was observed (Figure S7, Supporting Informa-
tion). In a GOx functionalized OECT, a large difference in the
steady state Id was observed between control and functionalized
biased gates (≈50% of the control signal) (Figure 4C), which is
in agreement with the calibration curves. In an LOx functional-
ized OECT, the Id steady state difference was not observed when
fresh media was added (Figure S8A, Supporting Information),
however, a difference in Id was observed after the cells were in-
cubated for 12 h with media (Figure S8B, Supporting Informa-
tion), indicating production of lactate from the cell metabolism.
The method of pulsing between a control and a functionalized
gate was used in order to discard any interference in the glucose
or lactate signal that is common in complex media. The control
gate provides a reference that does not change overtime.
As a proof of concept, continuous glucose measurements with
cells were performed in a time window of 24 h, by interchang-
ing the gate voltage between control and functionalized gate and
recording the changes in Id from a common OECT channel (Fig-
ure S9, Supporting Information). Our continuous measurement
system was not capable of applying alternating gate biases exactly
as used in previous characterization, in which the gate voltages
were switched manually, but rather two voltages were applied at
the OECT gates simultaneously. The effects of the measurement
system, which are shown in Figure S10 in the Supporting Infor-
mation, were taken into account to extract concentration changes
during this measurement. Figure 4D shows the normalized Id
current response (NR) between functionalized and control gate
over the course of 24 h, validating depletion of glucose by the
cells.
3. Conclusion
In this report, we fabricate micrometer scale OECT based enzy-
matic sensors that can monitor relevant metabolites at the direct
interface with the biological environment, without disrupting the
integrity of the biological system. This is made feasible by func-
tionalizing different enzymes in a stack that serve the desirable
functions of sensing, increasing biocompatibility, and decreasing
the interference. Electrodeposition of Pt-NPs was performed in
order to increase the catalytic activity of the gate for the turnover
of H2O2. We functionalized the gate by covalently binding the
biomolecules in a repeated order of PLL–GOx/LOx–PLL–HRP.
We optimized the ratios of the enzymes in order to be able to
sense in relevant metabolite concentrations but also limit the
amount of diffused peroxide. The OECT based sensors were able
to support the growth of MDCK II cells and monitor in situ the
glucose consumption from their metabolism. The biostack ap-
proach aims to improve the biocompatibility of metabolite sens-
ing platforms for applications that require metabolite monitoring
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at the interface with live cells and tissue. Examples of applica-
tions include metabolite sensing in brain tissue and drug toxicity
screening.
4. Experimental Section
Electrochemical Transistor Fabrication and Operation: The process, sim-
ilar to that reported previously, [27]included the deposition and pattern-
ing of gold, parylene C (PaC), and PEDOT:PSS:PVA. Source/drain contacts
were patterned by a lift-off process, using S1813 photoresist, exposed to
UV light through a SUSS MBJ4 contact aligner, and developed using MF-
26 developer. 5 nm of chromium and 100 nm of gold were subsequently
deposited using a metal evaporator, and metal lift-off was carried out in
acetone. Metal interconnects and pads were insulated by depositing 2 μm
of PaC using an specialty coating systems (SCS) Labcoater 2, and a silane
adhesion promoter. A dilute solution of industrial cleaner (Micro-90) was
subsequently spin coated to act as an antiadhesive for a second, sacrificial
PaC (2 μm) film. Samples were subsequently patterned with a thick layer
of AZ9260 photoresist (5 μm) and AZ developer (AZ Electronic Materi-
als). The patterned areas were opened by reactive ion etching with an oxy-
gen plasma using an Oxford 80 Plasmalab plus. PEDOT:PSS:PVA[25] with
GOPS (0.2% v/v) in solution was spin coated at 3000 rpm, and baked for
90 s in 100 °C. The second layer of parylene was peeled off with a subse-
quent rinsing in DI water and baking at 140 °C for 30 min.
Pt-NPs Deposition: Pt-NPs were electrodeposited by reducing Pt
ions. In more details, a solution containing chloroplatinic acid (H2PtCl6
5 × 10−3 m from Sigma-Aldrich) and sulfuric acid (H2SO4 50 × 10−3 m
from Sigma-Aldrich) was used in a three-electrode set up connected to a
Metroohm potentiostat. As reference electrode an Ag/AgCl was used, as
Counter electrode a Pt mesh, and as working electrode the planar gate
of the OECT. Pulse Voltammetry was used with initial potential Voff = +
0.7 versus Ag/AgCl—where no reduction occurred for 60 s and final poten-
tial Von = – 0.2 versus Ag/AgCl for 10 s where deposition of Pt occurred.
Subsequently, the devices were soaked in Di water overnight for the re-
moval of sulfuric acid, ethylene glycol, and dodecylbenzene sulfonic acid.
3-Glycidoxypropyltrimethoxysilane (GOPS) Deposition: GOPS was de-
posited by CVD. A pelco mini desiccator with an aluminum base was
placed on top of a hotplate and the temperature of the aluminum base
was kept at 90 °C and was continuously monitored by a thermometer. The
devices, as well as GOPS (200 μL) placed in an aluminum boat, were intro-
duced to the desiccator. Subsequently, a continuous vacuum was applied
by a pump connected to the desiccator. The deposition occurred for 1 h,
then the samples were thoroughly rinsed with Di water for the elimina-
tion of weakly bonded GOPS, and a subsequent baking step took place for
30 min at the same temperature to facilitate subsequent crosslinking of
silanol groups. During that step, glass cylindrical wells were placed on top
of the samples, and a thin strip of uncured polydimethylsiloxane (PDMS)
enabled a permanent sealing after curing.
PLL Coating: PLL solution (1 μL drops of a 0.01 wt% from Sigma-
Aldrich) was drop-casted on top of the gates and let for 3 h for reactions to
take place. The device was in a high vapor pressure atmosphere in order
to prevent evaporation of the droplets. Then the devices were thoroughly
rinsed with PBS and DI water in order to remove the unbound PLL.
Enzyme (GOx, LOx, HRP, Cat) Coating: Enzyme activation using
EDC/NHS: GOx (10 mg mL–1 from Sigma-Aldrich), LOx (kindly do-
nated by Roche), and HRP (Sigma-Aldrich) were separately mixed
with EDC and sulfo-NHS (50 × 10−3 m from Sigma-Aldrich) in 2-(N-
morpholino)ethanesulfonic acid (MES) buffer. The pH of the buffer was
adjusted to pH 6 by addition of NaOH. The mixture left for 30 min at room
temperature in order for the carboxylic acid to be activated to s-NHS ester.
Afterward, PBS 1X was added to the mixture in order to bring the pH to 7.4
and the desired final concentration of each enzyme. Finally, 2 μL of the ac-
tivated enzyme was drop-casted on top of each gate and let for 3 h for reac-
tions to take place (s-NHS group of the enzyme to bind to the NH2 group
of the PLL) in room temperature. The device was in a high vapor pressure
atmosphere in order to prevent evaporation of the droplets. The samples
were rinsed three times with PBS 10X and DI water. The same process
continued with alternation of enzyme layer of interest and PLL, in order
to create the biostack. All the steps were performed in sterile conditions.
Catalase was used in some of the experiments as an outmost enzyme layer
instead of HRP as in Figures S3 and S5 in the Supporting Information.
PEG-DA Hydrogel: PEG-DA (MW ≈ 6000 10 wt%) in DI water was
sonicated until a clear solution was obtained. Subsequently, 2-hydroxy-
2-methylpropiophenone (2 wt% from Sigma-Aldrich) photoinitiator was
introduced to the solution and mixed extensively. The hydrogel (1 μl) was
drop-casted on top of the gate and photopolymerized with a UV ≈ 365 nm
led array for 3 min (the time was kept short, in order to retain the struc-
ture and functionality of the enzyme). Finally, the devices were rinsed thor-
oughly with PBS 1X and DI water, and stored with PBS 1X in the fridge.
Cell Culture: Epithelial MDCK II cells (kindly donated by Dr. Frédéric
Luton, Institute of Cellular and Molecular Pharmacology, Valbonne,
France) were routinely maintained at 37 °C in a humidified atmosphere of
5% CO2 in complete Dulbecco’s Modified Eagle Medium (DMEM) (cD-
MEM) media (Dulbecco’s Modified Eagle Medium, fetal bovine serum
(10%), and Pen/Strep 5000 [U mL–1] penicillin–5000 [μg mL–1] strepto-
mycin). For all experiments, cells were incubated at an initial density of
6×104 cells/transwell insert (0.4 μm pore size, and area of 0.33 cm2) and
incubated until they reached confluence.
Device Operation: The measurements were performed using a Na-
tional Instruments PXIe-1062Q system. The channel of the OECT was bi-
ased using one channel of a source-measurement unit NI PXIe-4145. The
gate voltage was applied using an NI PXI-6289 modular instrument. In
the case of the IV-characteristics and transconductance characterization,
the drain current was measured using the system measurement unit. The
same channel was used for the bias. Concerning the time response char-
acterization of the OECT, one NI-PXI-4071 digital multimeter measured
drain current, and a channel of the NI PXI-6289 equipment measured gate
voltage. All the measurements were triggered through the built-in PXI ar-
chitecture. For the continuous glucose monitoring in MDCK II cells, two
voltages were applied simultaneously for every measurement, meaning
that, when the voltage in the functionalized gate was positive (V = 0.4 V)
the voltage at the control gate was at V = 0 V, and not in open circuit.
This lowers the effective gate voltage and thus the dedoping at the chan-
nel, lowering the normalized current response and shifting the sensitivity
toward catalysis of H2O2 (Figure S10, Supporting Information).
QCM Measurements: Samples were prepared as follows. QCM crys-
tals, if not new, were cleaned with Piranha solution, rinsed thoroughly
with di-water, and dried with N2. PEDOT:PSS:PVA was spin coated
(3000 rpm for 30 s) on QCM gold quartz crystals. Oxygen plasma (Oxford
instruments, Power: 100 W, O2 60 sccm, Pressure 100, time 120 s) was
done to improve film formation. GOPS was deposited by CVD as men-
tioned above. The crystals were inserted in the QCM-D (Biolin Scientific),
and the solutions with PLL and enzymes were flashed sequentially to cre-
ate the stack configuration. Once the frequency was shifting, the flow was
stopped in order for reactions to occur, and between each solution of in-
terest. PBS 1X was inserted as washing step, until the frequency was stabi-
lized. Each frequency curve was then extracted and normalized to the PBS
background.
Statistical Analysis: All data and statistical analysis was performed us-
ing MATLAB software from MathWorks. For the calibration curves in Fig-
ure 3B,C, three different samples (n = 3) for each condition and two time
series for each sample n were performed. The average and standard de-
viation was taken for each condition. The calibration curves in Figure S5
in the Supporting Information were fitted by using the Langmuir adsorp-






where K is the rate constant and Ch the concentration of H2O2. Figure S6
in the Supporting Information, the transconductance versus the frequency
was fitted with sinusoidal model by using a custom MATLAB function.
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